Crisaborole

DRUG7 trials

Sponsors

Duke University, University of Alabama at Birmingham, University of Rochester, Northwestern University, Johns Hopkins University

Conditions

Atopic DermatitisEczemaMorpheaPsoriasisSeborrheic Dermatitis

Phase 2

Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea

CompletedNCT03351114

Duke UniversityMorphea

Start: 2018-09-01End: 2020-03-10Updated: 2021-04-01

Phase 3

ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis

CompletedNCT03645057

University of RochesterAtopic Dermatitis

Start: 2019-02-20End: 2021-08-01Updated: 2022-10-31

Phase 4

A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis

CompletedNCT03567980

University of Alabama at BirminghamSeborrheic Dermatitis

Start: 2018-09-01End: 2021-05-12Updated: 2021-10-29

Steroid-reducing Effects of Crisaborole

CompletedNCT03832010

Johns Hopkins UniversityAtopic Dermatitis, Eczema

Start: 2019-12-17End: 2024-02-16Updated: 2024-07-19

Response of Children With Atopic Dermatitis (Eczema) to Eucrisa

CompletedNCT04023084

Ann & Robert H Lurie Children's Hospital of ChicagoAtopic Dermatitis, Eczema

Start: 2019-10-03End: 2022-02-11Updated: 2022-07-19

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

Not yet recruitingNCT07352566

University of California, San FranciscoAtopic Dermatitis, Psoriasis

Start: 2026-01-01End: 2030-06-01Target: 10Updated: 2026-01-20

Unknown Phase

Wearable Skin Sensors to Assess Nocturnal Scratch Behavior

CompletedNCT03770858

Northwestern UniversityAtopic Dermatitis

Start: 2019-04-18End: 2022-08-24Updated: 2023-10-13